Apply for NOME Startup Competition 2025
Specialising in ultra-sensitive, personalised blood tests that detect and monitor cancer by analysing circulating tumor DNA (ctDNA), enabling earlier diagnosis and more precise treatment tracking than conventional methods.
Visit website
Sweden
2025